Articles related to HEART ATTACK/MI

“The targeted vitamin D3 treatment group had half as many follow-up heart attacks as the control group—3.8% versus 7.9%.”

Women had a 45% higher relative risk for death, heart attack, or heart failure hospitalization when taking beta-blockers compared to non-beta-blocker groups, with the risk confined to those with preserved LVEF and higher doses.

“Heart disease runs in families, so if family members have had heart attacks, there’s a good chance you’re at risk.”

Research shows that women account for 50% of MINOCA cases but only 25% of myocardial infarctions due to obstructive coronary artery disease, highlighting the importance of considering this diagnosis in female patients presenting with MI symptoms.

A landmark analysis shows that physiology-guided complete revascularization reduced adverse outcomes by approximately 25% compared to culprit-only strategy across both STEMI and NSTEMI patients.

A network meta-analysis of 24 trials (16,371 patients) found complete revascularization in myocardial infarction with multivessel disease reduced all-cause mortality by 15% compared to culprit-only revascularization, suggesting potential improved outcomes for this population.